NBI-12i

the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Uremia 09/01/2007 - "We tested whether NBI-12i would also be effective in attenuating uremia-associated cachexia in a mouse model. " 09/01/2007 - "Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice."
2.	Cachexia 09/01/2007 - "We tested whether NBI-12i would also be effective in attenuating uremia-associated cachexia in a mouse model. " 09/01/2007 - "Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice."
3.	Weight Gain 09/01/2007 - "Intraperitoneal administration of NBI-12i stimulated food intake and weight gain in uremic mice. "

1.	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)